590 related articles for article (PubMed ID: 37249286)
1. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
[TBL] [Abstract][Full Text] [Related]
2. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
[TBL] [Abstract][Full Text] [Related]
3. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
[TBL] [Abstract][Full Text] [Related]
4. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the 'Italian factor'.
Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
Eur J Neurol; 2024 Feb; 31(2):e16094. PubMed ID: 37823707
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
[No Abstract] [Full Text] [Related]
7. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
Massa F; Vigo T; Bellucci M; Giunti D; Emanuela MM; Visigalli D; Capodivento G; Cerne D; Assini A; Boni S; Rizzi D; Narciso E; Grisanti GS; Coco E; Uccelli A; Schenone A; Franciotta D; Benedetti L
Neurol Sci; 2024 Mar; 45(3):849-859. PubMed ID: 38169013
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
[TBL] [Abstract][Full Text] [Related]
11. Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19.
Orak SA; Kubur ÇÇ; Atasever AK; Polat M
Arch Pediatr; 2023 May; 30(4):236-239. PubMed ID: 37069023
[TBL] [Abstract][Full Text] [Related]
12. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation.
Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M
J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
Front Immunol; 2021; 12():674922. PubMed ID: 34040615
[TBL] [Abstract][Full Text] [Related]
15. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-induced Guillain-Barre Syndrome: A Rare Complication of SARS-CoV-2 Infection.
Hanif M; Khan AW; Khan MA; Sundas F; Khan SJ
J Coll Physicians Surg Pak; 2021 Jul; 31(7):S123-S124. PubMed ID: 34271810
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
[TBL] [Abstract][Full Text] [Related]
18. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
Sii HL; Ng SH; Wong VF; Law WC
Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
[TBL] [Abstract][Full Text] [Related]
19. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
[TBL] [Abstract][Full Text] [Related]
20. Review article on COVID-19 and Guillain-Barré syndrome.
Patnaik UJ
Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]